ConductScience.org, home

Paper7979274

Licochalcone A, a new antimalarial agent, inhibits in vitro growth of the human malaria parasite Plasmodium falciparum and protects mice from P. yoelii infection.

Chen M and 5 others. Antimicrob Agents Chemother, 1994. Cited by 175 papers, by iCite.

Cite this record

ConductScience Library. Licochalcone A, a new antimalarial agent, inhibits in vitro growth of the human malaria parasite Plasmodium falciparum and protects mice from P. yoelii infection. Papers, record 7979274. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7979274

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Licochalcone A, a new antimalarial agent, inhibits in vitro growth of the human malaria parasite Plasmodium falciparum and protects mice from P. yoelii infection.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1994
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
175
iCite
Relative citation ratio, by iCite
6.76
iCite
Revised in PubMed
2022-03-18
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chen MM
2Theander TGT G
3Christensen SBS B
4Hviid LL
5Zhai LL
6Kharazmi AA

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AntimalarialsMajor topic
ChalconeMajor topic
MalariaMajor topic
Plasmodium falciparumMajor topic
Plasmodium yoeliiMajor topic
Animals
Chalcones
Chloroquine
Drug Resistance
Female
Hypoxanthines
Mice
Mice, Inbred BALB C

Source PubMed

Download CSV of topics

References25

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13887571Qinghaosu (artemisinin): an antimalarial drug from China.Science1985https://conductscience.org/library/papers/3887571PubMed
23530122Plants as sources of antimalarial drugs: in vitro antimalarial activities of some quassinoids.Antimicrob Agents Chemother1986https://conductscience.org/library/papers/3530122PubMed
317226224Antiprotozoal agents from plant sources.Planta Med1991https://conductscience.org/library/papers/17226224PubMed
42264669Plasmodium: resistance to antimalarial drugs.Ann Parasitol Hum Comp1990https://conductscience.org/library/papers/2264669PubMed
5781840Human malaria parasites in continuous culture.Science1976https://conductscience.org/library/papers/781840PubMed
62648881Stage specific actions of antimalarial drugs on Plasmodium falciparum in culture.Am J Trop Med Hyg1989https://conductscience.org/library/papers/2648881PubMed
72605703Identification of antimicrobial and antioxidant constituents from licorice of Russian and Xinjiang origin.Chem Pharm Bull (Tokyo)1989https://conductscience.org/library/papers/2605703PubMed
82632045Phenolic constituents of licorice. II. Structures of licopyranocoumarin, licoarylcoumarin and glisoflavone, and inhibitory effects of licorice phenolics on xanthine oxidase.Chem Pharm Bull (Tokyo)1989https://conductscience.org/library/papers/2632045PubMed
915462966Spread of chloroquine resistance in Plasmodium falciparum.Parasitol Today1987https://conductscience.org/library/papers/15462966PubMed
102572903Plasmodium vivax resistance to chloroquine?Lancet1989https://conductscience.org/library/papers/2572903PubMed
112183998Treatment of malaria--1990.Drugs1990https://conductscience.org/library/papers/2183998PubMed
126100431Bruceantin, a potent amoebicide from a plant, Brucea antidysenterica.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/6100431PubMed
132068748Medicinal plants in tropical medicine. 1. Medicinal plants against protozoal diseases.Trans R Soc Trop Med Hyg1991https://conductscience.org/library/papers/2068748PubMed
14383936Synchronization of Plasmodium falciparum erythrocytic stages in culture.J Parasitol1979https://conductscience.org/library/papers/383936PubMed
158092835Antileishmanial activity of licochalcone A in mice infected with Leishmania major and in hamsters infected with Leishmania donovani.Antimicrob Agents Chemother1994https://conductscience.org/library/papers/8092835PubMed
166759151Plasmodium falciparum: rapid assay for in vitro inhibition due to human serum from residents of malarious areas.Exp Parasitol1982https://conductscience.org/library/papers/6759151PubMed
171896519Inhibitory effects of licochalcone A isolated from Glycyrrhiza inflata root on inflammatory ear edema and tumour promotion in mice.Planta Med1991https://conductscience.org/library/papers/1896519PubMed
188109916Licochalcone A, a novel antiparasitic agent with potent activity against human pathogenic protozoan species of Leishmania.Antimicrob Agents Chemother1993https://conductscience.org/library/papers/8109916PubMed
192099092[HPLC analysis of flavonoids in the root of six Glycyrrhiza species].Yao Xue Xue Bao1990https://conductscience.org/library/papers/2099092PubMed
201484892Effects of three compounds extracted from Morinda lucida on Plasmodium falciparum.Planta Med1992https://conductscience.org/library/papers/1484892PubMed

See all 25 referencesDownload CSV of references

Cited by37

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 175 citations.

PMIDTitleJournalYearIn PapersSource
41484625Natural triterpenic phenolic esters target PfA-M17 in Plasmodium falciparum.Malar J2026https://conductscience.org/library/papers/41484625PubMed
40599794Pharmacological potential of natural chalcones: a recent studies and future perspective.Front Pharmacol2025https://conductscience.org/library/papers/40599794PubMed
40526092Reverse prenylation in plants by non-canonical aromatic prenyltransferases.Plant J2025https://conductscience.org/library/papers/40526092PubMed
39650850Identification of Coumarin-Chalcone and Coumarin-Pyrazoline Derivatives as Novel Anti-Toxoplasma gondii Agents.Drug Des Devel Ther2024https://conductscience.org/library/papers/39650850PubMed
39458571Combination Therapy and Phytochemical-Loaded Nanosytems for the Treatment of Neglected Tropical Diseases.Pharmaceutics2024https://conductscience.org/library/papers/39458571PubMed
39273572Medicinally Privileged Natural Chalcones: Abundance, Mechanisms of Action, and Clinical Trials.Int J Mol Sci2024https://conductscience.org/library/papers/39273572PubMed
38937401Significance of Chalcone Scaffolds in Medicinal Chemistry.Top Curr Chem (Cham)2024https://conductscience.org/library/papers/38937401PubMed
37711130Three Decades of Targeting Falcipains to Develop Antiplasmodial Agents: What have we Learned and What can be Done Next?Curr Med Chem2024https://conductscience.org/library/papers/37711130PubMed
36510199Antimalarial and immunomodulatory potential of chalcone derivatives in experimental model of malaria.BMC Complement Med Ther2022https://conductscience.org/library/papers/36510199PubMed
35744875Synthesis and Characterization of Novel Heterocyclic Chalcones from 1-Phenyl-1H-pyrazol-3-ol.Molecules2022https://conductscience.org/library/papers/35744875PubMed
35335918Sparsomycin Exhibits Potent Antiplasmodial Activity In Vitro and In Vivo.Pharmaceutics2022https://conductscience.org/library/papers/35335918PubMed
34808067Development of a novel anti-liver fibrosis formula with luteolin, licochalcone A, aloe-emodin and acacetin by network pharmacology and transcriptomics analysis.Pharm Biol2021https://conductscience.org/library/papers/34808067PubMed
34439870Chalcones: Synthetic Chemistry Follows Where Nature Leads.Biomolecules2021https://conductscience.org/library/papers/34439870PubMed
34189299Phytochemistry, pharmacological activity, and potential health benefits of Gly cyrrhiza glabra.Heliyon2021https://conductscience.org/library/papers/34189299PubMed
34187608Moringa oleifera extract promotes apoptosis-like death in Toxoplasma gondii tachyzoites in vitro.Parasitology2021https://conductscience.org/library/papers/34187608PubMed
34122058Anti-SARS-CoV-2 Natural Products as Potentially Therapeutic Agents.Front Pharmacol2021https://conductscience.org/library/papers/34122058PubMed
32347726Licochalcone A Selectively Resensitizes ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Drugs.J Nat Prod2020https://conductscience.org/library/papers/32347726PubMed
31910738Ex vivo efficacy of selective chalcone derivatives on reference strains and field isolates of Plasmodium falciparum.Pathog Glob Health2019https://conductscience.org/library/papers/31910738PubMed
31842914In vitro anti-malarial efficacy of chalcones: cytotoxicity profile, mechanism of action and their effect on erythrocytes.Malar J2019https://conductscience.org/library/papers/31842914PubMed
30123807Antiplasmodial Property of Glycyrrhiza glabra Traditionally Used for Malaria in Iran: Promising Activity with High Selectivity Index for Malaria.J Arthropod Borne Dis2018https://conductscience.org/library/papers/30123807PubMed

See all 37 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7979274

GET https://conductscience.org/api/papers/v1/7979274/references?page=2